Sr. Director/VP, Investor Relations

Company: Foghorn Therapeutics
Location: Cambridge
Posted on: February 17, 2021

Job Description:

Foghorn -- --Therapeutics is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Through its scalable Gene Traffic Control--- product platform, Foghorn is systematically interrogating and drugging the chromatin regulatory system. The Company, currently in pre-clinical stage, is advancing over 10 small molecule and protein degrader programs across a wide range of cancers. The company expects to file an IND for its first program later this year. Foghorn, a Flagship Pioneering -- --company, was founded in 2016 by Cigall Kadoch, Ph.D., Gerald Crabtree, M.D., and Doug Cole, M.D., of Flagship Pioneering. Learn more about Foghorn at-- www.foghorntx.com . About the Chromatin Regulatory System The chromatin regulatory system regulates gene expression by directing the movement of molecules that turn genes on and off. Disease dependencies associated with the chromatin regulatory system are estimated to impact over 2.5 million cancer patients across the United States, Europe and Japan. This system is further implicated in neurological, autoimmune, and other serious diseases. Job Summary The Senior Director/VP, Investor Relations is an important leadership role at Foghorn. This person will report to the Chief Financial Officer and work closely with the CEO and senior management team. S/He will have overall responsibility for shaping the investor communication strategy, manage interactions with buy-side, sell-side and other constituents, with the aim of increasing shareholder value and enhancing Foghorn's image in the investment community. Key Responsibilities

• Work closely with the senior leadership team on the development, integration and execution of the investor relations strategy
• Create and manage a targeting strategy for prospective investors; establish and nurture close relationships with key investors and Wall Street analysts
• Track Wall Street analysts' models, estimates, and pipeline expectations
• Continual refinement of messaging and market positioning based on company performance, market perception, expectations, peer performance and relative valuation
• Partner with senior leadership and work cross-functionally to support specific investor relation activities and creation of investor communications and events including analyst days, scientific meeting investor events and other investor focused communications
• Originate and maintain investor-facing materials, including all press releases, investor presentations, conference call scripts, Q&As, IR website and backgrounders
• Serve as an advisor to the CFO, CEO, and other senior leaders on issues involving the public distribution of financial information and other material disclosures
• Work in close partnership with internal legal team to review IR-related external communications and related 8-K filings
• Maintain master investor list and target communication lists; Track all investor interactions
• Develop a clear understanding of the segment mix of investor styles and needs
• Prepare executive management for investor events and earnings calls; Accompany and support senior executives at investor conferences and be a resource for information; Own and prepare investor presentations and key investor messages by working with multiple functional groups
• Keep abreast of industry trends and competitive landscape to both proactively and reactively adjust plans, messaging and manage relationships that may be impacted Qualifications
  • 6+ years' experience in the life sciences industry with a focus on investor relations, finance, equity research or investment banking
  • MBA and experience in the life sciences industry /or advanced science degree preferred
  • Experience successfully evolving an investor relations strategy as necessary for a rapidly growing and expanding business
  • Demonstrated success in building and elevating analyst coverage in an effort of continued corporate growth
  • Existing relationships within the financial, industry analyst, media, and institutional investor communities particularly in life sciences
  • Capable of independently writing clear, concise and error-free documents; Develop complex documents such as press releases, external company presentations, annual/quarterly reports, and brochures
  • Impeccable integrity and judgment skills, ability to deal with sensitive financial information and make recommendations to the CEO and CFO
  • A proactive, strategic approach to investor relations; Proven ability to plan, organize and execute IR-related events
  • Exhibit excellent verbal, interpersonal communications, and business writing skills
  • Possess a strong work ethic, be a self-starter, and be able to be highly productive in a dynamic, collaborative environment; Strong attention to detail and ability to be tactical and strategic

Keywords: Foghorn Therapeutics, Cambridge , Sr. Director/VP, Investor Relations, Accounting, Auditing , Cambridge, Massachusetts